Canada markets closed

Panbela Therapeutics, Inc. (PBLA)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.4100-0.0300 (-6.82%)
At close: 03:27PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.99M
Enterprise Value 4.61M
Trailing P/E 0.00
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.18

Trading Information

Stock Price History

Beta (5Y Monthly) 0.78
52-Week Change 3-99.85%
S&P500 52-Week Change 322.36%
52 Week High 3320.4000
52 Week Low 30.3500
50-Day Moving Average 30.7446
200-Day Moving Average 315.0998

Share Statistics

Avg Vol (3 month) 3470.67k
Avg Vol (10 day) 367.44k
Shares Outstanding 54.85M
Implied Shares Outstanding 64.85M
Float 84.85M
% Held by Insiders 10.00%
% Held by Institutions 10.16%
Shares Short (Feb 15, 2024) 4106.97k
Short Ratio (Feb 15, 2024) 40.07
Short % of Float (Feb 15, 2024) 43.07%
Short % of Shares Outstanding (Feb 15, 2024) 43.07%
Shares Short (prior month Jan 12, 2024) 446.36k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov 08, 2017
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Jan 18, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-191.05%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-34.4M
Diluted EPS (ttm)-316.5200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.58M
Total Cash Per Share (mrq)0.53
Total Debt (mrq)5.19M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.25
Book Value Per Share (mrq)-9.81

Cash Flow Statement

Operating Cash Flow (ttm)-25.25M
Levered Free Cash Flow (ttm)-9.86M